Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination
- PMID: 34862637
- PMCID: PMC9015495
- DOI: 10.1002/hep.32269
Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination
Conflict of interest statement
Nothing to report.
Figures

Comment on
-
Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: A rare adverse effect?Hepatology. 2022 Feb;75(2):489-490. doi: 10.1002/hep.32156. Epub 2021 Nov 27. Hepatology. 2022. PMID: 34528278 Free PMC article. No abstract available.
-
Letter to the editor: "Autoimmune hepatitis after COVID-19 vaccination".Hepatology. 2022 Mar;75(3):756. doi: 10.1002/hep.32249. Epub 2021 Dec 18. Hepatology. 2022. PMID: 34797931 Free PMC article. No abstract available.
References
-
- Medeiros‐Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, et al. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med. 2021;27:1744–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical